Review of National Insurance Claims Gives Insight into the Use and Misuse of Allergen-Specific, In Vitro Diagnostic Tests

J Appl Lab Med. 2020 Mar 1;5(2):417-419. doi: 10.1093/jalm/jfz014.

Authors

Jeannie M Stubblefield¹, Alyson N Mandel², Jane A Dickerson^{1

3}, Michael L Astion^{1

3}

Affiliations

¹ Department of Laboratory Medicine, University of Washington, Seattle, WA.
² eviCore Healthcare, Bluffton, SC.
³ Department of Laboratories, Seattle Children's Hospital, Seattle, WA.

PMID: 32445378
DOI: 10.1093/jalm/jfz014

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Allergens / immunology*
Cross-Sectional Studies
Diagnostic Tests, Routine / methods
Diagnostic Tests, Routine / standards*
Diagnostic Tests, Routine / statistics & numerical data*
Health Services Misuse / statistics & numerical data*
Humans
Immunoassay / methods
Immunoassay / standards*
Immunoassay / statistics & numerical data*
Immunoglobulin E / immunology
Insurance Claim Review*
National Health Programs
Washington / epidemiology

Substances

Allergens
Immunoglobulin E